Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research ...

Greater transparency between regulators and manufacturers can foster a better understanding of supply chain vulnerabilities ...

2024 was quite a year for significant strategic action among the pharmaceutical giants. Here are five key trends that will ...

ReactWise Introduces AI-Powered Technology to Transform the Global Pharmaceutical Industry.London, United Kingdom, January 8, ...

Pharmaceutical companies raised the list prices of at least 250 prescriptions heading into 2025 as major changes to the ...

Florida Governor DeSantis issued a statement in response to the report from the Grand Jury, tasked with investigating ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...

My colleague Andrew Nusca spoke with Mark Cuban last night at our annual Fortune Brainstorm Tech dinner at CES in Las Vegas.

The government has proposed extending the compliance deadline for revised Schedule M norms for pharmaceutical manufacturing.

Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it seeks to simplify its corporate structure.